Smithkline Beecham Limited v Nova Pharmaceuticals Australasia Pty Limited

Smithkline Beecham Limited (the opponent) opposed the registration of a trade mark by Nova Pharmaceuticals Australasia Pty Limited (the applicant). The opposition was brought under section 52 of the *Trade Marks Act 1995* (Cth), with grounds pursued under sections 42(b), 44, and 60 of the Act. The matter came before Tracey Berger J in the Federal Court of Australia.

The primary legal issue before the Court was whether the applicant's trade mark should be refused registration on any of the grounds pleaded by the opponent. Specifically, the Court was required to determine if the proposed mark was likely to deceive or cause confusion (section 42(b)), if it was substantially identical or deceptively similar to an earlier trade mark (section 44), or if its use would be contrary to law by reason of the opponent's rights under section 60.

The Court found that the ground under section 60 of the *Trade Marks Act 1995* was established. This section concerns the use of a trade mark that is identical or deceptively similar to a trade mark that has, by reason of its use or reputation, become well known to the opponent's target audience. The Court's reasoning, not detailed in the provided text, led to the conclusion that the applicant's mark infringed upon the opponent's rights under this provision.

Consequently, the Court ordered that the applicant's trade mark be refused registration.